{
    "code": "01049344",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01049344",
    "time": "2016-01-01 03:31:49",
    "許可證字號": "衛署藥製字第049344號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/03\/26",
    "發證日期": "97\/03\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104934402",
    "中文品名": "固栓宜膜衣錠 75 毫克",
    "英文品名": "Carvetone F.C. Tablets 75 mg",
    "適應症": "降低近期發生中風、心肌梗塞或周邊動脈血管疾病的粥狀動脈硬化病人之粥狀動脈硬化事件(如：心肌梗塞、中風或其他因血管病變引起的死亡)的發生。與aspirin併用降低非ST段上升之急性冠心病(不穩定性心絞痛和非Q波型心肌梗塞)病人。(包括經皮冠狀動脈介入性治療後放置支架的患者)之粥狀動脈栓塞事件。與Aspirin併用可用於以內科治療的ST段上升之急性心肌梗塞病人。",
    "劑型": "116膜衣錠",
    "包裝": "2~1000錠塑膠瓶裝 及鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "CLOPIDOGREL HYDROGEN SULFATE",
    "限制項目": [
        "01國產",
        "25監視中學名藥",
        "61完成BE試驗"
    ],
    "申請商名稱": "0402606200  中國化學製藥股份有限公司新豐工廠",
    "申請商地址": "新竹縣新豐鄉坑子口１８２之１號",
    "主製造廠": {
        "製造廠名稱": "0402602300  中國化學製藥股份有限公司新豐工廠",
        "製造廠廠址": "新竹縣新豐鄉坑子口182-1號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012600210",
            "成分名稱": "CLOPIDOGREL HYDROGEN SULFATE",
            "含量描述": "(eq. to Clopidogrel 75mg)",
            "含量": "97.8750000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Carvetone FCT In-104-11-19.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=006&Type=9"
        },
        {
            "title": "Carvetone FCT In-104-02-25.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=005&Type=9"
        },
        {
            "title": "0204934400002___20110504.JPG",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=004&Type=9"
        },
        {
            "title": "0204934400001___20110504.JPG",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=003&Type=9"
        },
        {
            "title": "010493440002.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=002&Type=9"
        },
        {
            "title": "010493440001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=001&Type=9"
        },
        {
            "title": "Carvetone La-104-11-19.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=007&Type=8"
        },
        {
            "title": "Carvetone F.C. Tablets 75 mg Box-104-11-19.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=006&Type=8"
        },
        {
            "title": "Carvetone La-104-02-25.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=005&Type=8"
        },
        {
            "title": "Carvetone F.C. Tablets 75 mg Box-104-02-25.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=004&Type=8"
        },
        {
            "title": "0204934400003___20110504.JPG",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=003&Type=8"
        },
        {
            "title": "010493440002.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=002&Type=8"
        },
        {
            "title": "010493440001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=001&Type=8"
        }
    ]
}